During the past decade, Hospital General de Segovia conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 6 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 1 clinical trials were completed. i.e. 9.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital General de Segovia" #1 sponsor was "PETHEMA Foundation" with 22 trials, followed by "Celgene" with 3 trials sponsored, "Fundación GECP" with 3 trials sponsored, "Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General de Segovia" #1 collaborator was "Celgene" with 3 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator, "Asociación Científica Pulmón y Ventilación Mecánica" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Adknoma" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Hospital General de Segovia" are "Multiple Myeloma" (12 trials), "Acute Lymphoblastic Leukemia" (5 trials), "Lung Cancer" (3 trials), "Diffuse Large B-cell Lymphoma" (2 trials) and "Leukemia Myeloid Acute" (2 trials). Many other conditions were trialed in "Hospital General de Segovia" in a lesser frequency.

Most popular intervention types in "Hospital General de Segovia" are "Drug" (32 trials), "Other" (4 trials), "Procedure" (3 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (7 trials), "Prednisone" (6 trials), "Melphalan" (4 trials), "Cyclophosphamide" (3 trials) and "Daunorubicin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital General de Segovia" are 45 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital General de Segovia". 1 are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Hospital General de Segovia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital General de Segovia, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 1 trials that are defined as “Not Applicable".

Hospital General de Segovia has several departments that took part in Clinical trials: "Hospital General de Segovia; Servicio de Oncologia" - 3 trials